Metraipolis › archive › dc_c6613e757331

Integrated bioinformatics and experimental validation identifies SOX2 as a key therapeutic target for chronic atrophic gastritis/gastric cancer-depression… — Europe PMC PMID:42741006

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42741006
DOI
10.3389/fonc.2026.1858473
License (as archived)
solo-consultazione
Archived
2026-10-08T15:02:08.179Z
SHA-256 of the archived text
1adca13df2f9ab1ba684c973e19ab2c4090eeb1c01384d11e5b2dd7cace32b50
Stable URL of this page
https://metraipolis.com/documento/dc_c6613e757331

How to cite

Integrated bioinformatics and experimental validation identifies SOX2 as a key therapeutic target for chronic atrophic gastritis/gastric cancer-depression… — Europe PMC PMID:42741006 — Europe PMC (en), https://europepmc.org/article/MED/42741006 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c6613e757331 (Metraipolis archive dc_c6613e757331, sha256 1adca13df2f9ab1ba684c973e19ab2c4090eeb1c01384d11e5b2dd7cace32b50)
BibTeX
@misc{dcc6613e757331,
  title = {Integrated bioinformatics and experimental validation identifies SOX2 as a key therapeutic target for chronic atrophic gastritis/gastric cancer-depression… — Europe PMC PMID:42741006},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42741006},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c6613e757331; sha256 1adca13df2f9ab1ba684c973e19ab2c4090eeb1c01384d11e5b2dd7cace32b50},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42741006. Agents can read the archived copy with the MCP tool read_document.